Baker Brothers Advisors - TEKMIRA PHARMACEUTICALS CORP ownership

TEKMIRA PHARMACEUTICALS CORP's ticker is TKMR and the CUSIP is 87911B209. A total of 54 filers reported holding TEKMIRA PHARMACEUTICALS CORP in Q1 2014. The put-call ratio across all filers is 0.38 and the average weighting 0.1%.

Quarter-by-quarter ownership
Baker Brothers Advisors ownership history of TEKMIRA PHARMACEUTICALS CORP
ValueSharesWeighting
Q2 2015$2,142,000
-32.1%
180,5820.0%0.02%
-26.9%
Q1 2015$3,153,000
-57.0%
180,582
-62.7%
0.03%
-65.3%
Q4 2014$7,335,000
-28.3%
484,1560.0%0.08%
-41.9%
Q3 2014$10,235,000
+61.9%
484,1560.0%0.13%
+67.5%
Q2 2014$6,323,000
-39.2%
484,1560.0%0.08%
-41.7%
Q1 2014$10,405,000
+161.1%
484,156
-3.2%
0.13%
+135.7%
Q4 2013$3,985,000500,0000.06%
Other shareholders
TEKMIRA PHARMACEUTICALS CORP shareholders Q1 2014
NameSharesValueWeighting ↓
QVT Financial LP 16,013,540$279,596,00015.57%
RA Capital Management 2,714,800$47,400,0004.71%
Alpha Wave Global, LP 2,221,000$38,779,0001.90%
Redmile Group, LLC 700,000$12,222,0001.10%
HealthCor Management, L.P. 718,800$12,550,0000.60%
Monashee Investment Management LLC 55,000$960,0000.60%
SPHERA FUNDS MANAGEMENT LTD. 298,486$5,212,0000.54%
Telemetry Investments, L.L.C. 48,000$838,0000.46%
Anson Funds Management LP 25,000$437,0000.39%
Blue Ridge Capital, L.L.C. 1,700,000$29,682,0000.34%
View complete list of TEKMIRA PHARMACEUTICALS CORP shareholders